company

UNI PHARMA HOLDING AS

8178 HALSA

Return on Equity
23,59 %
Current Ratio
1,89
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue150 000
Net Income88 000
Total Assets592 000
Total Equity373 000
Income (NOK)2022
Revenue150 000
Expenditure64 000
Operating Profit86 000
Financial Income2 000
Financial Costs0
Financial Balance2 000
Earnings Before Tax88 000
Tax0
Net Income88 000
Balance (NOK)2022
Total Fixed Assets177 000
Total Current Assets415 000
Total Assets592 000
Total Retained Equity140 000
Total Equity373 000
Total Long-Term Debt0
Total Current Debt219 000
Total Equity and Debt592 000
Cash flow (NOK)2022
Sales Income150 000
Other Income0
Revenue150 000
Cost of Goods Sold0
Salary Costs0
Depreciation0
Impairment0
Expenditure64 000
Operating Profit86 000
Financial Income2 000
Financial Costs0
Financial Balance2 000
Dividends0
Net Income88 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets177 000
Total Fixed Assets177 000
Stock0
Total Investments0
Cash, Bank413 000
Total Current Assets415 000
Total Assets592 000
Total Equity373 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors2 000
Unpaid Taxes0
Dividends0
Other Current Debt217 000
Total Current Debt219 000
Total Equity and Debt592 000
Financial indicators2022
Return on Equity23,59 %
Debt-to-Equity Ratio0
Operating Profit Margin57,33 %
Current Ratio1,89
Quick Ratio1,89
Equity Ratio0,63
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English